Markets:

Overview

News

Currencies

International

Treasuries

ICON plc - Ordinary Shares (NQ:ICLR)

168.53 +4.19 (+2.55%)

Delayed Quote Updated: 11:20 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

ICON plc Schedules Second Quarter 2022 Earnings Conference Call

June 21, 2022

From ICON plc

Via Business Wire

4 Analysts Have This to Say About Icon ↗

May 24, 2022

Analysts have provided the following ratings for Icon (NASDAQ:ICLR) within the last quarter:

Via Benzinga

ICON plc to present at the H.C. Wainwright Global Investment Conference and the Jefferies Healthcare Conference

May 23, 2022

From ICON plc

Via Business Wire

ICON Named Business & Finance Company of the Year and One of Forbes’ Best Employers for Diversity

May 23, 2022

From ICON

Via Business Wire

Expert Ratings for Icon ↗

April 25, 2022

Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter:

Via Benzinga

Recap: Icon Q4 Earnings ↗

February 22, 2022

Icon (NASDAQ:ICLR) reported its Q4 earnings results on Tuesday, February 22, 2022 at 06:15 AM. Check out this: Insiders Buy More Than $170M Of 4 Stocks Here's what...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022 ↗

May 24, 2022

Upgrades

Via Benzinga

ICON plc to present at the BofA Securities 2022 Healthcare Conference

May 03, 2022

From ICON plc

Via Business Wire

Expert Ratings For Icon ↗

September 27, 2021

Over the past 3 months, 6 analysts have published their opinion on Icon (NASDAQ:

Via Benzinga

ICON Reports First Quarter 2022 Results

April 27, 2022

From ICON plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022 ↗

April 25, 2022

Via Benzinga

How This Top CEO Helped Pfizer Turbocharge The Covid-19 Vaccine ↗

March 31, 2022

When Covid-19 stalled the world's economic motor in early 2020, ICON CEO Steve Cutler and his team at the vaccine trials company revved up.

Via Investor's Business Daily

Ominous Death Cross Forms On Icon's Chart ↗

March 15, 2022

If history is any guide, there may be trouble ahead for shares of Icon (NASDAQ:ICLR). A so-called "death cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

March 07, 2022

Wells Fargo raised the price target on Lockheed Martin Corporation (NYSE: LMT) from $400 to $486. Lockheed Martin shares rose 1.3% to $464.10 in pre-market trading....

Via Benzinga

Expert Ratings For Icon ↗

February 25, 2022

Icon (NASDAQ:ICLR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 3 0...

Via Benzinga

ICON Reports Fourth Quarter and Full Year 2021 Results

February 22, 2022

From ICON plc

Via Business Wire

Earnings Scheduled For February 21, 2022 ↗

February 21, 2022

Companies Reporting After The Bell • Unisys (NYSE:UIS) is estimated to report quarterly earnings at $0.36 per share on revenue of $539.80 million. • Icon (NASDAQ:...

Via Benzinga

Earnings Outlook For Icon ↗

February 18, 2022

Icon (NASDAQ:ICLR) is set to give its latest quarterly earnings report on Monday, 2022-02-21. Here's what investors need to know before the announcement. Analysts estimate that Icon will report an...

Via Benzinga

ICON plc to Present at the 2022 Citi Healthcare Conference

February 17, 2022

From ICON plc

Via Business Wire

ICON Issues Financial Guidance for Full Year 2022

January 12, 2022

From ICON

Via Business Wire

ICON plc to Present at the 40th Annual JP Morgan Healthcare Conference

January 05, 2022

From ICON plc

Via Business Wire

Composite Rating For ICON Rises To 96; Awaits Breakout ↗

December 08, 2021

The IBD SmartSelect Composite Rating ICON stock rose from 94 to 96 Wednesday as the Ireland-based clinical researcher approaches a buy point.

Via Investor's Business Daily

ICON Named Best Contract Research Organisation in Latest String of Industry Awards

December 07, 2021

From ICON plc

Via Business Wire

ICON Releases Environmental, Social and Governance Report

November 22, 2021

From ICON plc

Via Business Wire

PerkinElmer Stock, Already Highly Rated, Perks Up Further Amid Brisk Sales, Profit Growth For Its Instruments ↗

November 11, 2021

A Relative Strength Rating upgrade for PerkinElmer shows improving technical performance. Will it continue?

Via Investor's Business Daily

ICON Announces the Expansion of its Accellacare Site Network

November 10, 2021

From ICON plc

Via Business Wire

Icon PLC (ICLR) Q3 2021 Earnings Call Transcript ↗

November 06, 2021

ICLR earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

ICON plc to Present at the 30th Annual Credit Suisse Healthcare Conference and the 4th Annual Evercore ISI HealthCONx Conference

November 05, 2021

From ICON plc

Via Business Wire

ICON Reports Third Quarter 2021 Results

November 03, 2021

From ICON plc

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 ↗

September 27, 2021

Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

ICON plc - Ordinary Shares (NQ:ICLR)

All News about ICON plc - Ordinary Shares

Starting at /week.